522 related articles for article (PubMed ID: 16163893)
1. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
[TBL] [Abstract][Full Text] [Related]
2. [Effects of specific cycloxygenase-2 inhibition on the renal functions of ederly patients with renal function impairment].
Horáková M; Schück O; Komers R; Teplan V; Charvát J; Kvapil M
Cas Lek Cesk; 2006; 145(10):777-81. PubMed ID: 17121069
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake.
Huledal G; Jonzon B; Malmenäs M; Hedman A; Andersson LI; Odlind B; Brater DC
Clin Pharmacol Ther; 2005 May; 77(5):437-50. PubMed ID: 15900289
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
[TBL] [Abstract][Full Text] [Related]
6. Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?
Aw TJ; Liew D; Tofler GH; Schneider HG; Morel-Kopp MC; Billah B; Krum H
J Hypertens; 2006 Oct; 24(10):1979-84. PubMed ID: 16957557
[TBL] [Abstract][Full Text] [Related]
7. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
[TBL] [Abstract][Full Text] [Related]
8. Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake.
Höcherl K; Kammerl MC; Schumacher K; Endemann D; Grobecker HF; Kurtz A
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F294-301. PubMed ID: 12110513
[TBL] [Abstract][Full Text] [Related]
9. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
Schwartz JI; Vandormael K; Malice MP; Kalyani RN; Lasseter KC; Holmes GB; Gertz BJ; Gottesdiener KM; Laurenzi M; Redfern KJ; Brune K
Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
[TBL] [Abstract][Full Text] [Related]
10. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
Farker K; Merkel U; Schweer H; Haerting J; Madani SF; Eggers R; Müller UA; Seyberth HW; Hoffmann A
Eur J Clin Pharmacol; 2002 May; 58(2):85-91. PubMed ID: 12012138
[TBL] [Abstract][Full Text] [Related]
11. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
[TBL] [Abstract][Full Text] [Related]
12. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Vogt L; de Zeeuw D; Woittiez AJ; Navis G
Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
[TBL] [Abstract][Full Text] [Related]
13. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
14. Effect of NH4Cl acidosis on the function of renin-angiotensin-aldosterone system in newborn infants.
Adamovich K; Sulyok E; Jaton T; Guignard JP
J Dev Physiol; 1992 Jul; 18(1):9-12. PubMed ID: 1287079
[TBL] [Abstract][Full Text] [Related]
15. Does high salt intake cause hyperfiltration in patients with essential hypertension?
Mallamaci F; Leonardis D; Bellizzi V; Zoccali C
J Hum Hypertens; 1996 Mar; 10(3):157-61. PubMed ID: 8733032
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.
Willette RN; Eybye ME; Olzinski AR; Behm DJ; Aiyar N; Maniscalco K; Bentley RG; Coatney RW; Zhao S; Westfall TD; Doe CP
J Pharmacol Exp Ther; 2009 Sep; 330(3):964-70. PubMed ID: 19556450
[TBL] [Abstract][Full Text] [Related]
17. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
[TBL] [Abstract][Full Text] [Related]
18. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.
Onuigbo MA; Onuigbo NT
Ren Fail; 2008; 30(1):67-72. PubMed ID: 18197546
[TBL] [Abstract][Full Text] [Related]
19. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
20. [Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease].
Martín MV; Barroso S; Herráez O; de Sande F; Caravaca F
Nefrologia; 2006; 26(4):433-8. PubMed ID: 17058854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
